Back to search
FDAFDA · Food and drugs·Recall number Z-1369-2026

Estrone RIA, REF: DSL8700

Published February 25, 2026 · Recall initiated: December 15, 2025

Summary

FDA records medical device Class II recall Z-1369-2026, published February 25, 2026 and initiated December 15, 2025. Recalling firm: Immunotech A.S.; Status: Ongoing; Reported quantity: 160; Lot: UDI: 15099590211615. Lot(Expiration): 251013C(2025-12-30), 251110C(2026-01-27). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The affected Estrone RIA kit lots may rarely give falsely high patient results which might cause Temporary injury of Remote probability. Only in some (very rare) cases may the issue occur.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Immunotech A.S.
Distributor
Worldwide - US Nationwide distribution in the state of NC and the countries of Germany, Argentina, Netherlands, Hungary, Austria, Belgium, France, Italy.
Lot
UDI: 15099590211615. Lot(Expiration): 251013C(2025-12-30), 251110C(2026-01-27)
Risk classification
Class II
Area (FDA)
device
Country
Czech Republic

Related recalls

Questions about this recall

Was Estrone RIA, REF: DSL8700 recalled?

Yes. FDA published recall Z-1369-2026 on February 25, 2026. Reported hazard: The affected Estrone RIA kit lots may rarely give falsely high patient results which might cause Temporary injury of Remote probability. Only in some (very rare) cases may the issue occur.

What should I do if I have this product?

Voluntary: Firm initiated · Letter